Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Saghmos Therapeutics to Present at the 25th BioCentury Future Leaders Conference in New York

Saghmos Therapeutics,Inc.
Posted on: 20 Mar 18

Saghmos Therapeutics, Inc., a privately held biopharmaceutical company whose mission is to prevent and treat kidney injury due to contrast dyes, today announced that it will present at the 25thBioCenturyFuture Leaders conference New York City.

Anna Kazanchyan, M.D., Chief Executive Officer and Chairwoman of Saghmos, will provide an overview of the company and its lead program, ST-62516, which is positioned to enter Phase 3 development to improve cardiorenal outcomes in patients undergoing percutaneous coronary intervention (PCI). The presentation is scheduled for Friday, March 23, 2018, at 2pm EDT in Room 402/403 at the Millennium Broadway Hotel & Conference Center in New York, NY.

About Saghmos Therapeutics
Saghmos Therapeutics is a privately held biopharmaceutical company whose mission is to prevent and treat kidney injury due to contrast dyes. Saghmos’ lead program, ST-62516 is positioned to enter Phase 3 development for reduction of major adverse renal and cardiac events (MARCE) associated with contrast-induced acute kidney injury (CI-AKI) in patients undergoing percutaneous coronary intervention (PCI). CI-AKI is a silent killer, leading to heart attacks, prolonged hospitalization, need for dialysis and death. It is a multi-billion dollar market opportunity, with no FDA-approved drugs for prevention or treatment.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180320006034/en/

Business Wire
www.businesswire.com

Last updated on: 20/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.